Skip to content

The effect of implantation of biventricular pacemaker with or without defibrillator on blood vessels function and electrical changes in the hearts of patients with severe heart failure

The effect of implantation of biventricular pacemaker with or without defibrillator on endothelial functions and electrical and mechanical cardiac remodelling in patients with severe heart failure after 6months.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12615000895583
Acronym
InCARP
Enrollment
33
Registered
2015-08-27
Start date
2013-08-06
Completion date
2015-09-04
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

The planned studies will evaluate the central-peripheral interactions in cardiac resynchronisation therapy to determine the changes induced by the process and their various roles in modulating overall clinical response in patients with heart failure

Interventions

Implantation of biventricular pacemaker with or without automatic implantable defibrillator according to conventional indications. The approximate duration of the implantation procedure is 2 to 3 hours

Sponsors

The Queen Elizabeth Hospital Research Foundation
Lead SponsorHospital

Study design

Allocation
Non-randomised trial
Intervention model
Single group
Primary purpose
Treatment
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

Patients in whom CRT with or without Implantable Cardioverter Defibrillator (ICD) insertion is planned will be eligible for the study irrespective of the bases underlying heart failure

Exclusion criteria

a. Inability to attend for follow-up evaluation b. Treatment with inhibition of platelet ADP receptor activation e.g Clopidogrel c. Anticipated limitation of exercise capacity due to non cardiac disease eg Severe COPD d. Severe renal failure, Creatinine >3mg/dl (265.2micromol/L) or on dialysis. e. Expected life expantancy less than 1 year due to non cardiac causes f. Inability to give informed consent

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026